ABSTRACT
Background For some common cancers, survival is lower in the UK than in comparable high-income countries.
Aim To assess the effectiveness of a targeted postal intervention (promoting awareness of cancer symptoms and earlier help-seeking) on patient consultation rates.
Design and Setting A two-arm randomised controlled trial (RCT) of adult patients registered at 23 general practices in England.
Method Adult patients who had not consulted their general practice in the previous 12 months and had at least two other risk factors for late presentation with cancer were randomised to intervention and control arms. The intervention consisted of a mailed letter. The primary outcome was number of consultations at the practice in the six months subsequent to mailing of the intervention. All patients with outcome data were included in the intention-to-treat analyses. The trial was registered prospectively on the International Standard Randomised Controlled Trial Number (ISRCTN) registry (ISRCTN95610478).
Results 1,513 patients were individually randomised to the intervention (n=783) and control (n=730) arms, between November 2016 and May 2017. Outcome data was available for 749 and 705 patients respectively. There was a significantly higher rate of consultation in the intervention arm: 436 consultations compared to 335 in the control arm (RR = 1.40, 95% CI 1.11-1.77, p=0.004). However, there was no difference in the numbers of patients consulting.
Conclusion Targeted interventions of this nature can change behaviour. There is a need to develop interventions which can be more effective at engaging patients with primary care.
HOW THIS FITS IN Later stage of cancer diagnosis is associated with poorer survival and may arise from low symptom awareness and from delays in presenting to primary care. Population-wide campaigns to increase awareness and encourage help-seeking have shown mixed results in terms of stage at diagnosis and numbers of primary care consultations. This randomised controlled trial was targeted at a population whose circumstances would suggest that should they develop cancer, they are at increased risk of being diagnosed with later stage disease. This study demonstrates targeted interventions of this nature can change consultation behaviour of those who are likely to benefit most from earlier symptomatic presentation.
Competing Interest Statement
Funding for the study is detailed in the manuscript. All authors have completed the ICMJE uniform disclosure form at www.icmje.org/coi_disclosure.pdf and declare: grants from the National Institute of Health Research for the submitted work (SWD, PS, JPL, DV, and DP), a fellowship from Cancer Research UK (SQ); no financial relationships with any organisations that might have an interest in the submitted work in the previous three years; no other relationships or activities that could appear to have influenced the submitted work.
Clinical Trial
ISRCTN95610478
Funding Statement
This research is funded by the National Institute for Health Research (NIHR) Policy Research Programme, conducted through the Policy Research Unit in Cancer Awareness, Screening and Early Diagnosis, 106/0001. The views expressed are those of the author(s) and not necessarily those of the NIHR or the Department of Health and Social Care. SLQ is supported by a Cancer Research UK postdoctoral fellowship (C50664/A24460). The study funders were not involved in the design or analysis of the study. Additional support, including NHS service support costs, were provided by the National Institute for Health Research Clinical Research Network (NIHR CRN) (UKCRN ID 31163).
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Ethical approval was granted by the West of Scotland Research Ethics Service (WoSREC) (reference 16/WS/0110). The study was approved by the Health Research Authority (HRA) (reference 201992).
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
The relevant anonymised patient level data will be made available on reasonable request to the corresponding author.